Drug Approval | March 23, 2024
Zydus receives tentative approval from USFDA for Letermovir Tablets
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The drug will target specific genetic mutations prevalent in certain types of cancers
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
ANVISA issues CGMP to Concord Biotech’s Unit I
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
Subscribe To Our Newsletter & Stay Updated
